|
Stories from the dialysis comunity across the globe.
|
|
Morgan Joseph Initiates Coverage on Genzyme (GENZ) with a Buy - StreetInsider.com (subscription) |
 |
 |
|
Renal develops, manufactures and distributes products that treat patients suffering from renal diseases, including chronic renal failure. read more |
|
|
Tengion to Present at 27th Annual JP Morgan Healthcare Conference - PR Newswire (press release) |
|
|
|
"Kidney regeneration from patients' own cells would become the standard of care for chronic renal failure therapy. Tengion's work on the neo-kidney is an ... read more |
|
First NxStage Home Hemodialysis Patients Celebrate Five-Year ... - PR Newswire (press release) |
|
|
|
For Carl, who was diagnosed with kidney failure in 1996, in-center dialysis had been a physically grueling as well as intensely time-consuming process. ... read more |
|
|
First NxStage Home Hemodialysis Patients Celebrate Five-Year Anniversary (PR Newswire via Yahoo! Finance) |
|
|
|
NxStage Medical, Inc. , a leading manufacturer of innovative dialysis products, today announced that a group of its first patients are celebrating their five-year anniversary of home hemodialysis treatment with the NxStage® System One, the first truly portable home hemodialysis machine. read more |
|
Phase III Trial Begins For GAMMAGARD LIQUID Plus RHuPH20 In Primary Immunodeficiency Patients (Medical News Today) |
|
|
|
Baxter International Inc. and Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced the start of a Phase III clinical trial of Baxter's GAMMAGARD LIQUID [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze(TM) Technology) for the treatment of primary immunodeficiency (PID). read more |
|
|
|
|
<< Start < Prev 4041 4042 4043 4044 4045 4046 4047 4048 4049 4050 Next > End >>
|
|
Page 4049 of 4210 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
